ESR1 and breast carcinoma: Furthermore, our data showing that NO results in a MEK/ERK/Ets-1 signaling cascade in ER-/HER2+ SKBR3 cells [see Additional file 4: Figure S3] suggest that high NOS2 expression and NO signaling may induce proliferative and aggressive phenotypes in HER2+ breast cancer.